<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32686212</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>27</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1440-1789</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Neuropathology : official journal of the Japanese Society of Neuropathology</Title><ISOAbbreviation>Neuropathology</ISOAbbreviation></Journal><ArticleTitle>Praja1 RING-finger E3 ubiquitin ligase suppresses neuronal cytoplasmic TDP-43 aggregate formation.</ArticleTitle><Pagination><StartPage>570</StartPage><EndPage>586</EndPage><MedlinePgn>570-586</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/neup.12694</ELocationID><Abstract><AbstractText>Transactivation response DNA-binding protein of 43 kDa (TDP-43) is a major constituent of cytoplasmic aggregates in neuronal and glial cells in cases of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). We have previously shown neuronal cytoplasmic aggregate formation induced by recombinant adenoviruses expressing human wild-type and C-terminal fragment (CTF) TDP-43 under the condition of proteasome inhibition in vitro and in vivo. In the present study, we demonstrated that the formation of the adenoviral TDP-43 aggregates was markedly suppressed in rat neural stem cell-derived neuronal cells by co-infection of an adenovirus expressing heat shock transcription factor 1 (HSF1), a master regulator of heat shock response. We performed DNA microarray analysis and searched several candidate molecules, located downstream of HSF1, which counteract TDP-43 aggregate formation. Among these, we identified Praja 1 RING-finger E3 ubiquitin ligase (PJA1) as a suppressor of phosphorylation and aggregate formation of TDP-43. Co-immunoprecipitation assay revealed that PJA1 binds to CTF TDP-43 and the E2-conjugating enzyme UBE2E3. PJA1 also suppressed formation of cytoplasmic phosphorylated TDP-43 aggregates in mouse facial motor neurons in vivo. Furthermore, phosphorylated TDP-43 aggregates were detected in PJA1-immunoreactive human ALS motor neurons. These results indicate that PJA1 is one of the principal E3 ubiquitin ligases for TDP-43 to counteract its aggregation propensity and could be a potential therapeutic target for ALS and FTLD.</AbstractText><CopyrightInformation>&#xa9; 2020 The Authors. Neuropathology published by John Wiley &amp; Sons Australia, Ltd on behalf of Japanese Society of Neuropathology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Watabe</LastName><ForeName>Kazuhiko</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-0245-3834</Identifier><AffiliationInfo><Affiliation>Department of Medical Technology (Neuropathology), Kyorin University, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, Tokyo Women's Medical University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kato</LastName><ForeName>Yoichiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pathology, Tokyo Women's Medical University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakuma</LastName><ForeName>Miho</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7834-0529</Identifier><AffiliationInfo><Affiliation>School of Medicine, Tokyo Women's Medical University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murata</LastName><ForeName>Makiko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Technology (Neuropathology), Kyorin University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niida-Kawaguchi</LastName><ForeName>Motoko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pathology, Tokyo Women's Medical University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takemura</LastName><ForeName>Taro</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Research Network and Facility Services Division, National Institute for Materials Science, Tsukuba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanagata</LastName><ForeName>Nobutaka</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Research Network and Facility Services Division, National Institute for Materials Science, Tsukuba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tada</LastName><ForeName>Mari</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pathology, Brain Research Institute, Niigata University, Niigata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kakita</LastName><ForeName>Akiyoshi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pathology, Brain Research Institute, Niigata University, Niigata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shibata</LastName><ForeName>Noriyuki</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-7173-5061</Identifier><AffiliationInfo><Affiliation>Department of Pathology, Tokyo Women's Medical University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Collaborative Research Project (2017-2019) of Brain Research Institute, Niigata University</Agency><Country/></Grant><Grant><GrantID>15K06763, 18K06507</GrantID><Agency>Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (JSPS KAKENHI)</Agency><Country/></Grant><Grant><Agency>Niigata University</Agency><Country/></Grant><Grant><Agency>Ministry of Education</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Neuropathology</MedlineTA><NlmUniqueID>9606526</NlmUniqueID><ISSNLinking>0919-6544</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000076249">Heat Shock Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="D044767">Ubiquitin-Protein Ligases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003593" MajorTopicYN="N">Cytoplasm</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000076249" MajorTopicYN="N">Heat Shock Transcription Factors</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066263" MajorTopicYN="N">Protein Aggregation, Pathological</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057177" MajorTopicYN="N">TDP-43 Proteinopathies</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044767" MajorTopicYN="N">Ubiquitin-Protein Ligases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Praja1</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">adenovirus</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">frontotemporal lobar degeneration</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32686212</ArticleId><ArticleId IdType="pmc">PMC7818255</ArticleId><ArticleId IdType="doi">10.1111/neup.12694</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Blokhuis AM, Groen EJ, Koppers M, van den Berg LH, Pasterkamp RJ. Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol 2013; 125: 777&#x2013;794.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3661910</ArticleId><ArticleId IdType="pubmed">23673820</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH Jr, Cleveland DW. Decoding ALS: From genes to mechanism. Nature 2016; 539: 197&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Berning BA, Walker AK. The pathobiology of TDP&#x2010;43 C&#x2010;terminal fragments in ALS and FTLD. Front Neurosci 2019; 13: 335.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6470282</ArticleId><ArticleId IdType="pubmed">31031584</ArticleId></ArticleIdList></Reference><Reference><Citation>Hergesheimer RC, Chami AA, de Assis DR et al The debated toxic role of aggregated TDP&#x2010;43 in amyotrophic lateral sclerosis: A resolution in sight? Brain 2019; 142: 1176&#x2013;1194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6487324</ArticleId><ArticleId IdType="pubmed">30938443</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad A, Bharathi V, Sivalingam V, Girdhar A, Patel BK. Molecular mechanisms of TDP&#x2010;43 misfolding and pathology in amyotrophic lateral sclerosis. Front Mol Neurosci 2019; 12: 25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6382748</ArticleId><ArticleId IdType="pubmed">30837838</ArticleId></ArticleIdList></Reference><Reference><Citation>Robberecht W, Philips T. The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci 2013; 14: 248&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotter EL, Vance C, Nishimura AL et al Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP&#x2010;43 species. J Cell Sci 2014; 127: 1263&#x2013;1278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3953816</ArticleId><ArticleId IdType="pubmed">24424030</ArticleId></ArticleIdList></Reference><Reference><Citation>Watabe K, Akiyama K, Kawakami E et al Adenoviral expression of TDP&#x2010;43 and FUS genes and shRNAs for protein degradation pathways in rodent motoneurons in vitro and in vivo. Neuropathology 2014; 34: 83&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">23937386</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishii T, Kawakami E, Endo K, Misawa H, Watabe K. Formation and spreading of TDP&#x2010;43 aggregates in cultured neuronal and glial cells demonstrated by time&#x2010;lapse imaging. PLoS One 2017; 12: e0179375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5466347</ArticleId><ArticleId IdType="pubmed">28599005</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Del Tredici K, Lee VM, Trojanowski JQ. Spreading of pathology in neurodegenerative diseases: A focus on human studies. Nat Rev Neurosci 2015; 16: 109&#x2013;120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4312418</ArticleId><ArticleId IdType="pubmed">25588378</ArticleId></ArticleIdList></Reference><Reference><Citation>Jucker M, Walker LC. Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases. Nat Neurosci 2018; 21: 1341&#x2013;1349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6375686</ArticleId><ArticleId IdType="pubmed">30258241</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng C, Trojanowski JQ, Lee VM. Protein transmission in neurodegenerative disease. Nat Rev Neurol 2020; 16: 199&#x2013;212.</Citation><ArticleIdList><ArticleId IdType="pubmed">32203399</ArticleId></ArticleIdList></Reference><Reference><Citation>Dayalan Naidu S, Dinkova&#x2010;Kostova AT. Regulation of the mammalian heat shock factor 1. FEBS J 2017; 284: 1606&#x2013;1627.</Citation><ArticleIdList><ArticleId IdType="pubmed">28052564</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez&#x2010;Pastor R, Burchfiel ET, Thiele DJ. Regulation of heat shock transcription factors and their roles in physiology and disease. Nat Rev Mol Cell Biol 2018; 19: 4&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5794010</ArticleId><ArticleId IdType="pubmed">28852220</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin PY, Folorunso O, Taglialatela G, Pierce A. Overexpression of heat shock factor 1 maintains TAR DNA binding protein 43 solubility via induction of inducible heat shock protein 70 in cultured cells. J Neurosci Res 2016; 682: 671&#x2013;682.</Citation><ArticleIdList><ArticleId IdType="pubmed">26994698</ArticleId></ArticleIdList></Reference><Reference><Citation>Crippa V, Cicardi ME, Ramesh N et al The chaperone HSPB8 reduces the accumulation of truncated TDP&#x2010;43 species in cells and protects against TDP&#x2010;43&#x2010;mediated toxicity. Hum Mol Genet 2016; 25: 3908&#x2013;3924.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5291228</ArticleId><ArticleId IdType="pubmed">27466192</ArticleId></ArticleIdList></Reference><Reference><Citation>Crippa V, D&#x2019;Agostino VG, Cristofani R et al Transcriptional induction of the heat shock protein B8 mediates the clearance of misfolded proteins responsible for motor neuron diseases. Sci Rep 2016; 6: 22827.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4785366</ArticleId><ArticleId IdType="pubmed">26961006</ArticleId></ArticleIdList></Reference><Reference><Citation>Cristofani R, Crippa V, Vezzoli G et al The small heat shock protein B8 (HSPB8) efficiently removes aggregating species of dipeptides produced in C9ORF72&#x2010;related neurodegenerative diseases. Cell Stress Chaperones 2018; 23: 1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5741577</ArticleId><ArticleId IdType="pubmed">28608264</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganassi M, Mateju D, Bigi I et al A surveillance function of the HSPB8&#x2010;BAG3&#x2010;HSP70 chaperone complex ensures stress granule integrity and dynamism. Mol Cell 2016; 63: 796&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pubmed">27570075</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HJ, Mitchell JC, Novoselov S et al The heat shock response plays an important role in TDP&#x2010;43 clearance: Evidence for dysfunction in amyotrophic lateral sclerosis. Brain 2016; 139:1417&#x2013;1432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4845254</ArticleId><ArticleId IdType="pubmed">26936937</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P, Wander CM, Yuan CX, Bereman MS, Cohen TJ. Acetylation&#x2010;induced TDP&#x2010;43 pathology is suppressed by an HSF1&#x2010;dependent chaperone program. Nat Commun 2017; 8: 82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5517419</ArticleId><ArticleId IdType="pubmed">28724966</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory JM, Whiten DR, Brown RA et al Clusterin protects neurons against intracellular proteotoxicity. Acta Neuropathol Commun 2017; 5: 81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5678579</ArticleId><ArticleId IdType="pubmed">29115989</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishii T, Kawakami E, Endo K, Misawa H, Watabe K. Myelinating cocultures of rodent stem cell line&#x2010;derived neurons and immortalized Schwann cells. Neuropathology 2017; 37: 475&#x2013;481.</Citation><ArticleIdList><ArticleId IdType="pubmed">28707715</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai S, Takagi Y, Kaneko S, Kurosawa T. Effect of three types of mixed anesthetic agents alternate to ketamine in mice. Exp Anim 2011; 60: 481&#x2013;487.</Citation><ArticleIdList><ArticleId IdType="pubmed">22041285</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa M, Arai T, Nonaka T et al Phosphorylated TDP&#x2010;43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol 2008; 64: 60&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2674108</ArticleId><ArticleId IdType="pubmed">18546284</ArticleId></ArticleIdList></Reference><Reference><Citation>Igaz LM, Kwong LK, Chen&#x2010;Plotkin A et al Expression of TDP&#x2010;43 C&#x2010;terminal fragments in vitro recapitulates pathological features of TDP&#x2010;43 proteinopathies. J Biol Chem 2009; 284: 8516&#x2013;8524.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2659210</ArticleId><ArticleId IdType="pubmed">19164285</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendillo ML, Santagata S, Koeva M et al. HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers. Cell 2012; 150: 549&#x2013;562.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3438889</ArticleId><ArticleId IdType="pubmed">22863008</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra L, Tully RE, Monga SP et al Praja1, a novel gene encoding a RING&#x2010;H2 motif in mouse development. Oncogene 1997; 15: 2361&#x2013;2368.</Citation><ArticleIdList><ArticleId IdType="pubmed">9393880</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki A, Masuda Y, Iwai K, Ikeda K, Watanabe K. A RING finger protein Praja1 regulates Dlx5&#x2010;dependent transcription through its ubiquitin ligase activity for the Dlx/Msx&#x2010;interacting MAGE/Necdin family protein, Dlxin&#x2010;1. J Biol Chem 2002; 277: 22541&#x2013;22546.</Citation><ArticleIdList><ArticleId IdType="pubmed">11959851</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu P, Chen Y, Tagle DA, Cai T. PJA1, encoding a RING&#x2010;H2 finger ubiquitin ligase, is a novel human X chromosome gene abundantly expressed in brain. Genomics 2002; 79: 869&#x2013;874.</Citation><ArticleIdList><ArticleId IdType="pubmed">12036302</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoabi M, Sadeh R, de Bie P, Marquez VE, Ciechanover A. PRAJA1 is a ubiquitin ligase for the polycomb repressive complex 2 proteins. Biochem Biophys Res Commun 2011; 408: 393&#x2013;398.</Citation><ArticleIdList><ArticleId IdType="pubmed">21513699</ArticleId></ArticleIdList></Reference><Reference><Citation>Voellmy R. Dominant&#x2010;positive and dominant&#x2010;negative heat shock factors. Methods 2005; 35: 199&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">15649847</ArticleId></ArticleIdList></Reference><Reference><Citation>Loch CM, Eddins MJ, Strickler JE. Protein microarrays for the identification of praja1 E3 ubiquitin ligase substrates. Cell Biochem Biophys 2011; 60: 127&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pubmed">21461837</ArticleId></ArticleIdList></Reference><Reference><Citation>Aulas A, Vande Velde C. Alterations in stress granule dynamics driven by TDP&#x2010;43 and FUS: A link to pathological inclusions in ALS? Front Cell Neurosci 2015; 9: 423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4615823</ArticleId><ArticleId IdType="pubmed">26557057</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Cohen TJ. Aggregation of the nucleic acid&#x2010;binding protein TDP&#x2010;43 occurs via distinct routes that are coordinated with stress granule formation. J Biol Chem 2019; 294: 3696&#x2013;3706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6416430</ArticleId><ArticleId IdType="pubmed">30630951</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolozin B, Ivanov P. Stress granules and neurodegeneration. Nat Rev Neurosci 2019; 20: 649&#x2013;666.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6986315</ArticleId><ArticleId IdType="pubmed">31582840</ArticleId></ArticleIdList></Reference><Reference><Citation>Loganathan S, Lehmkuhl EM, Eck RJ, Zarnescu DC. To Be or Not To Be &#x2026; Toxic&#x2010;Is RNA association with TDP&#x2010;43 complexes deleterious or protective in neurodegeneration? Front Mol Biosci 2020; 6: 154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6965497</ArticleId><ArticleId IdType="pubmed">31998750</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha T, Vardhini D, Tang Y et al RING finger&#x2010;dependent ubiquitination by PRAJA is dependent on TGF&#x2010;beta and potentially defines the functional status of the tumor suppressor ELF. Oncogene 2006; 25: 693&#x2013;705.</Citation><ArticleIdList><ArticleId IdType="pubmed">16247473</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Mitra A, Li S et al Targeting the E3 ubiquitin ligase PJA1 enhances tumor&#x2010;suppressing TGF&#x2010;&#x3b2; signaling. Cancer Res 2020. 10.1158/0008-5472.CAN-19-3116, 80, 1819, 1832.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-19-3116</ArticleId><ArticleId IdType="pmc">PMC7704101</ArticleId><ArticleId IdType="pubmed">32127355</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunda S, Heir P, Metcalf J et al CIC protein instability contributes to tumorigenesis in glioblastoma. Nat Commun 2019; 10: 661.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6368580</ArticleId><ArticleId IdType="pubmed">30737375</ArticleId></ArticleIdList></Reference><Reference><Citation>Consalvi S, Brancaccio A, Dall&#x2019;Agnese A, Puri PL, Palacios D. Praja1 E3 ubiquitin ligase promotes skeletal myogenesis through degradation of EZH2 upon p38&#x3b1; activation. Nat Commun 2017; 8: 13956.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5423270</ArticleId><ArticleId IdType="pubmed">28067271</ArticleId></ArticleIdList></Reference><Reference><Citation>Stork O, Stork S, Pape HC, Obata K. Identification of genes expressed in the amygdala during the formation of fear memory. Learn Mem 2001; 8: 209&#x2013;219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC311378</ArticleId><ArticleId IdType="pubmed">11533224</ArticleId></ArticleIdList></Reference><Reference><Citation>Wieland I, Weidner C, Ciccone R et al Contiguous gene deletions involving EFNB1, OPHN1, PJA1 and EDA in patients with craniofrontonasal syndrome. Clin Genet 2007; 72: 506&#x2013;516.</Citation><ArticleIdList><ArticleId IdType="pubmed">17941886</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayama M, Miyake T, Gahara Y, Ohara O, Kitamura T. A novel RING&#x2010;H2 motif protein downregulated by axotomy: Its characteristic localization at the postsynaptic density of axosomatic synapse. J Neurosci 1995; 15: 5238&#x2013;5248.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6577874</ArticleId><ArticleId IdType="pubmed">7623148</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W, Ma C, Zhang Q et al PJA1 coordinates with the SMC5/6 complex to restrict DNA viruses and episomal genes in an interferon&#x2010;independent manner. J Virol 2018; 92: e00825&#x2010;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6206484</ArticleId><ArticleId IdType="pubmed">30185588</ArticleId></ArticleIdList></Reference><Reference><Citation>Hebron ML, Lonskaya I, Sharpe K et al. Parkin ubiquitinates Tar&#x2010;DNA binding protein&#x2010;43 (TDP&#x2010;43) and promotes its cytosolic accumulation via interaction with histone deacetylase 6 (HDAC6). J Biol Chem 2013; 288: 4103&#x2013;4115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3567661</ArticleId><ArticleId IdType="pubmed">23258539</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchida T, Tamaki Y, Ayaki T et al CUL2&#x2010;mediated clearance of misfolded TDP&#x2010;43 is paradoxically affected by VHL in oligodendrocytes in ALS. Sci Rep 2016; 6: 19118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4707540</ArticleId><ArticleId IdType="pubmed">26751167</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YC, Huang WC, Lin JH et al. Znf179 E3 ligase&#x2010;mediated TDP&#x2010;43 polyubiquitination is involved in TDP&#x2010;43&#x2010; ubiquitinated inclusions (UBI) (+)&#x2010;related neurodegenerative pathology. J Biomed Sci 2018; 25: 76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6223059</ArticleId><ArticleId IdType="pubmed">30404641</ArticleId></ArticleIdList></Reference><Reference><Citation>Hans F, Fiesel FC, Strong JC et al UBE2E ubiquitin&#x2010;conjugating enzymes and ubiquitin isopeptidase Y regulate TDP&#x2010;43 protein ubiquitination. J Biol Chem 2014; 289: 19164&#x2013;19179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4081952</ArticleId><ArticleId IdType="pubmed">24825905</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldenberg SJ, Marblestone JG, Mattern MR, Nicholson B. Strategies for the identification of ubiquitin ligase inhibitors. Biochem Soc Trans 2010; 38: 132&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3060714</ArticleId><ArticleId IdType="pubmed">20074047</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabrielsen M, Buetow L, Nakasone MA et al A general strategy for discovery of inhibitors and activators of RING and U&#x2010;box E3 ligases with ubiquitin variants. Mol Cell 2017; 68: 456&#x2013;470.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5655547</ArticleId><ArticleId IdType="pubmed">29053960</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>